货号:GS40315
Gulgafafusp alfa is an investigational, human immunoglobulin G2 kappa (IgG2κ) monoclonal antibody being developed for the treatment of metabolic diseases, particularly type 2 diabetes (T2D) and potentially obesity. It represents a novel biologic approach by targeting the glucagon-like peptide 1 receptor (GLP1R).
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯